Zobrazeno 1 - 2
of 2
pro vyhledávání: '"companion imaging agents"'
Autor:
Bailly, Clément, Chalopin, Benjamin, Gouard, Sébastien, Carlier, Thomas, Remaud-Le Saec, Patricia, Marionneau-Lambot, Séverine, Moreau, Philippe, Touzeau, Cyrille, Kraeber-Bodéré, Françoise, Bodet-Milin, Caroline, Chérel, Michel
Publikováno v:
Cancers
Cancers, MDPI, 2020, 12 (6), pp.1467. ⟨10.3390/cancers12061467⟩
Cancers, Vol 12, Iss 1467, p 1467 (2020)
Cancers, 2020, 12 (6), pp.1467. ⟨10.3390/cancers12061467⟩
Cancers, MDPI, 2020, 12 (6), pp.1467. ⟨10.3390/cancers12061467⟩
Cancers, Vol 12, Iss 1467, p 1467 (2020)
Cancers, 2020, 12 (6), pp.1467. ⟨10.3390/cancers12061467⟩
International audience; Despite constant progress over the past three decades, multiple myeloma (MM) is still an incurable disease, and the identification of new biomarkers to better select patients and adapt therapy is more relevant than ever. Recen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::4ea30bfdb8f2082c4665cad31b24a2f7
https://www.hal.inserm.fr/inserm-02881836
https://www.hal.inserm.fr/inserm-02881836
Autor:
Bailly C; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France.; Nuclear Medicine Department, University Hospital of Nantes, 44093 Nantes, France., Chalopin B; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France., Gouard S; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France., Carlier T; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France.; Nuclear Medicine Department, University Hospital of Nantes, 44093 Nantes, France., Saëc PR; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France., Marionneau-Lambot S; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France., Moreau P; Department of Hematology, University Hospital of Nantes, 44093 Nantes, France., Touzeau C; Department of Hematology, University Hospital of Nantes, 44093 Nantes, France., Kraeber-Bodere F; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France.; Nuclear Medicine Department, University Hospital of Nantes, 44093 Nantes, France.; Nuclear Medicine Department, ICO-René Gauducheau Cancer Center, 44800 Saint-Herblain, France., Bodet-Milin C; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France.; Nuclear Medicine Department, University Hospital of Nantes, 44093 Nantes, France., Chérel M; CRCINA, INSERM, CNRS, Université d'Angers, Université de Nantes, 44093 Nantes, France.; Nuclear Medicine Department, ICO-René Gauducheau Cancer Center, 44800 Saint-Herblain, France.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Jun 04; Vol. 12 (6). Date of Electronic Publication: 2020 Jun 04.
